Skip to search formSkip to main contentSkip to account menu

Haemophilus influenzae B Ab:MCnc:Pt:Ser:Qn

Known as: Haemophilus influenzae B Ab:KütlKons:Zml?:Ser:Kant, Haem influ B Ac Ser-mCnc, Haem influ B Ab Ser-mCnc 
National Institutes of Health

Related topics

Related topics

10 relations
AntibodiesBlood group antigen BHaemophilus influenzaeHaemophilus influenzae B

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination.
2009
2009
New Vaccines Against Otitis Media: Projected Benefits and Cost-effectiveness
OBJECTIVE. New vaccines that offer protection against otitis media caused by nontypeable Haemophilus influenzae and by Moraxella… 
Review
2006
Review
2006
The Alaska Haemophilus influenzae Type b Experience: Lessons in Controlling a Vaccine-Preventable Disease
OBJECTIVE. Before 1991, Alaska Native children experienced one of the highest rates of invasive Haemophilus influenzae type b… 
2005
2005
[Vaccination failure: case report of Haemophilus influenzae b meningitis in a 14-month-old child].
BACKGROUND The generalization of the vaccination against H. influenzae b (Hib), according to its integration in the French… 
1991
1991
Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
OBJECTIVE To evaluate the immunologic potential of infants 7 to 15 months of age to respond to Haemophilus influenzae type b… 
1987
1987
SUBCELLULAR LOCATION OF MAC-1 (CR-3) IN HUMAN NEUTROPHILS: EFFECTS OF CHEMOTACTIC FACTORS AND PMA
Induction of surface Mac-1 by inflammatory stimuli is fundamental to a broad spectrum of granulocyte adherence reactions. To… 
1987
1987
1gG2 SUBCLASS DEFICIENCY PRESENTING AS H. INFLUENZAE B (HIB) DISEASE AFTER IMMUNIZATION WITH HIB VACCINE
Twenty-six healthy children previously immunized (imm) with the Hib capsular polysaccharide (Hib CP) vaccine at age 19 to 38 mos… 
Highly Cited
1985
Highly Cited
1985
Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.
Hemophilus influenzae type b (HIB) is the leading cause of bacterial meningitis in the United States. Efforts are under way to… 
Highly Cited
1984
Highly Cited
1984
Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.
A long-term follow-up of approximately 50,000 children who received the Hemophilus influenzae type b capsular polysaccharide… 
1977
1977
[Effectiveness of intranasal immunization with Myxovirus influenzae neuraminidase in mice].
An intranasal immunization with a A/PR8/34-isolated NA, protected mice as well as the whole virus and A/Hong Kong/1/68 virus… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License